This technology is a design and manufacturing method for microneedle arrays to precisely deliver therapeutic materials to difficult-to-reach anatomical locations.
Current methods to deliver therapeutic materials across anatomical barriers to enclosed spaces in the eye, ear, and central nervous system are inherently inaccurate and may cause functional damage to sensory systems. Additionally, such methods are typically one-time dosing treatments, limiting the potential therapeutic efficacy. Microneedle arrays have been adapted for rapid and painless drug injection across the skin. However, microneedle geometry and materials need to be optimized for application in specific anatomical barriers in sensory systems.
This technology describes design and manufacturing methods for ultra-sharp microneedle arrays for therapeutic delivery across anatomic barriers in the eye, ear, and central nervous system. With the advancement of two-photon lithography, microneedles arrays can be manufactured with micron-level precision and complex geometry optimized for anatomic barriers. Variable biodegradable materials enable the microneedles to decompose slowly after injection, preventing functional damage and allowing for controlled and continued release of medicine over preferred time intervals.
This technology has been validated in vitro and across the inner ear of guinea pig models.
IR CU18171, CU18172, CU18280, CU19233, CU20008
Licensing Contact: Dovina Qu